|
Market Closed -
Nasdaq
05:00:00 11/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 245.43 USD | +0.77% |
|
+6.83% | +44.37% |
| 11-03 | RBC Raises Price Target on Jazz Pharmaceuticals to $305 From $296, Keeps Outperform Rating | MT |
| 11-03 | Jazz Pharmaceuticals plc, Q3 2026 Earnings Call, Nov 02, 2026 |
| Market Cap | 15.75B 14.13B 13.02B 11.82B 22.38B 1,477B 23B 156B 62.11B 791B 59.12B 57.87B 2,502B | P/E 2026 * |
61.7x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 18.51B 16.6B 15.29B 13.89B 26.29B 1,735B 27.02B 183B 72.97B 930B 69.45B 67.98B 2,939B | EV / Sales 2026 * |
3.85x | EV / Sales 2027 * | 3.31x |
| Free-Float |
96.81% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| JAZZ | Delayed | |
CBOE
| JAZZ | Real-time | |
|
Tradegate
| J7Z | Real-time | |
|
Boerse Muenchen
| J7Z | Real-time | |
|
Deutsche Boerse AG
| J7Z | Delayed | |
|
Börse Stuttgart
| J7Z | Delayed | |
|
Berne S.E.
| J7Z | End-of-day quote | |
|
Borsa Italiana
| 1JAZZ | End-of-day quote | |
|
Xetra
| J7Z | Delayed |
Last Transcript: Jazz Pharmaceuticals plc
| 1 day | +0.77% | ||
| 1 week | +6.83% | ||
| Current month | +13.64% | ||
| 1 month | +12.37% | ||
| 3 months | -4.32% | ||
| 6 months | +8.70% | ||
| Current year | +44.37% |
| 1 week | 225.5 |  | 246.47 |
| 1 month | 202.3 | | 246.47 |
| Current year | 156.95 | | 266.38 |
| 1 year | 136.27 | | 266.38 |
| 3 years | 95.49 | | 266.38 |
| 5 years | 95.49 | | 266.38 |
| 10 years | 86.88 | | 266.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renée Galá
CEO | Chief Executive Officer | 54 | 11/08/2025 |
Philip Johnson
DFI | Director of Finance/CFO | 62 | 01/03/2024 |
Mary Henderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CHM | Chairman | 62 | 01/03/2003 |
Seamus Mulligan
BRD | Director/Board Member | 65 | 18/01/2012 |
Rick Winningham
BRD | Director/Board Member | 66 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/11/26 | Sell | Chief Executive Officer | -1,000 | 0.0015% | ||
| 2/11/26 | Sell | Founder | -6,000 | 0.0092% | ||
| 6/10/26 | Sell | Chief Executive Officer | -2,000 | 0.0031% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.77% | +6.83% | +84.27% | +104.18% | 15.75B | |
| +1.44% | +1.63% | +48.17% | +139.63% | 1,276B | |
| -0.47% | +5.49% | +49.03% | +90.68% | 676B | |
| +0.20% | +2.76% | +34.37% | +112.06% | 519B | |
| +0.17% | +2.76% | +44.07% | +69.71% | 388B | |
| -0.48% | +2.34% | +70.66% | +46.02% | 365B | |
| +0.76% | +2.27% | +31.59% | +60.36% | 307B | |
| -1.29% | +0.90% | +5.77% | +37.60% | 287B | |
| 0.00% | +0.86% | +43.74% | +74.04% | 252B | |
| +0.92% | +2.03% | +44.62% | +125.07% | 212B | |
| Average | +0.05% | +2.79% | +45.63% | +85.94% | 430B | |
| Weighted average by Cap. | -0.09% | +2.53% | +43.86% | +97.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.8B 4.31B 3.97B 3.61B 6.83B 450B 7.02B 47.55B 18.94B 241B 18.03B 17.65B 763B | 5.05B 4.53B 4.17B 3.79B 7.17B 473B 7.37B 49.98B 19.91B 254B 18.95B 18.55B 802B |
| Net income | 290M 260M 240M 218M 413M 27.23B 424M 2.87B 1.15B 14.59B 1.09B 1.07B 46.12B | 1.17B 1.05B 964M 875M 1.66B 109B 1.7B 11.54B 4.6B 58.59B 4.38B 4.28B 185B |
| Net Debt | 2.75B 2.47B 2.27B 2.07B 3.91B 258B 4.02B 27.23B 10.85B 138B 10.33B 10.11B 437B | 975M 874M 806M 732M 1.38B 91.41B 1.42B 9.65B 3.84B 48.97B 3.66B 3.58B 155B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | US$245.43 | +0.77% | 576,714 |
| 09/11/26 | US$243.55 | +3.74% | 886,048 |
| 06/11/26 | US$234.76 | +3.27% | 887,563 |
| 05/11/26 | US$227.32 | -3.13% | 670,559 |
| 04/11/26 | US$234.66 | +2.14% | 899,091 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- JAZZ Stock
Select your edition
All financial news and data tailored to specific country editions
